Dexterra Group, Inc. · TSX:DXT
Dexterra — Q2 2026 Earnings Presentation
16 slides from Dexterra's earnings presentation, Aug 5, 2026
Slide 1: Q2 2026 Results Analyst & Investor Call
Q2 2026 Results Analyst & Investor Call August 5, 2026 1
Slide 2: Cautionary Statement
Cautionary Statement the seasonality of Dexterra’s business; inability to restore or replace critical capacity in a timely manner; In this presentation, all amounts are in Canadian dollars, unless otherwise indicated. Any reputational, competitive and financial risk related to cyber-attacks and brea
Slide 3: Bill McFarland, Chair of the Board
Bill McFarland Chair of the Board Dexterra Q2 2026 Presentation 3 3
Slide 4: Mark Becker, Chief Executive Officer
Mark Becker Chief Executive Officer Dexterra Q2 2026 Presentation 4 4
Slide 5: Q2: Strong Financial Performance & Growth
Q2 2026 Revenue and Adjusted EBITDA(1) ($ millions) Q2: Strong Financial Performance & Growth • Strong revenue driven by workforce accommodation occupancy, organic growth, and acquisitions • Strong Adjusted EBITDA and margins • Improved free cash flow for Q2 and YTD YTD Q2 2026 Revenue and Adjusted
Slide 6: Denise Achonu, Chief Financial Officer
Denise Achonu Chief Financial Officer Dexterra Q2 2026 Presentation 6 6
Slide 7: Support Services Review
Q2 2026 Revenue and Adjusted EBITDA(1) ($ millions) Support Services Review A suite of facilities management, remote services, and hospitality solutions with an expanding footprint • High workforce accommodation occupancy, organic growth, and the addition of Right Choice • Adjusted EBITDA growth of
Slide 8: Asset Based Services Review
Q2 2026 Revenue and Adjusted EBITDA(1) ($ millions) Asset Based Services Review Workforce accommodation structures and access matting for clients in the natural resources and infrastructure sectors • Higher margin rental revenue growth of 13% • Adjusted EBITDA margin expansion from increased contrib
Slide 9: Strong Financial Position And Disciplined Capital Allocation
Strong Financial Position And Disciplined Capital Allocation • Positive working capital reduction in Q2 • Annual Adjusted EBITDA conversion to FCF to exceed 50% • Planned U.S. platform and IT investments progressing • Flexibility for high return growth investments/acquisitions • Significant credit f
Slide 10: Outlook and Priorities
Outlook and Priorities • Continued strong execution and profitable, predictable results • Continue to scale our U.S. platform • North-American FM/IFM expansion • Pursue U.S. data centre and Canadian Nation-Building opportunities • Manage inflationary pressures • Deliver shareholder value through dis
Slide 11: Q&A
Q&A 11
Slide 12: Appendix I - Supporting Charts
Appendix I - Supporting Charts
Slide 13: Revenue Reconciliation Q2 2026 vs. Q2 2025
Revenue Reconciliation Q2 2026 vs. Q2 2025 Dexterra Q2 2026 Presentation 13
Slide 14: Revenue Reconciliation YTD Q2 2026 vs. YTD Q2 2025
Revenue Reconciliation YTD Q2 2026 vs. YTD Q2 2025 Dexterra Q2 2026 Presentation 14
Slide 15: Adjusted EBITDA Reconciliation Q2 2026 vs. Q2 2025
Adjusted EBITDA Reconciliation Q2 2026 vs. Q2 2025 Dexterra Q2 2026 Presentation 15
Slide 16: Adjusted EBITDA Reconciliation YTD Q2 2026 vs. YTD Q2 2025
Adjusted EBITDA Reconciliation YTD Q2 2026 vs. YTD Q2 2025 Dexterra Q2 2026 Presentation 16